Wegovy and Mounjaro now reimbursed in France for obesity treatment

Anti-obesity treatments Wegovy and Mounjaro now benefit from reimbursement in France, improving patient access.

Published 7sem2 sources✓ ConfirmedNotable

≈ 21sSpeed

The fact

This decision responds to rising obesity cases and offers a major therapeutic alternative to overweight patients.

Reimbursement expands access to these innovative medicines previously available only to wealthy patients.

2 sources — click a link to read an article on the topic:

Explore this topic

Jun 16Wegovy and Mounjaro now reimbursed in France for obesity treatmentthis article

Auto-synthesis from 2 media sources · identified on June 16, 2026